-
While the alleged fraud is shocking, could it suggest the industry is under-investing in claims? -
This is in large part due to the current legal environment and inflation continuing to push medical pricing up.
-
A quick roundup of today’s need-to-know news, including Y&A's PE deal.
-
The losses are "well above expectations" and above 2024 cat loss guidance.
-
Return on capital employed hit 13% last year as the cost of capital fell to 8%.
-
The financing will further the growth of Risk Strategies and One80 Intermediaries.
-
Current backer CIVC will retain a minority stake in Y&A alongside management and staff.
-
The deal covered US and European P&C liabilities for Accelerant's 2020-2021 underwriting years.
-
Sanchez will report to Carolina Carmona, LSM’s head of financial lines in south Florida.
-
The P&C industry reported its best Q2 combined ratio since 2021, but was still a loss-making underwriting result.
-
The decision comes weeks before the rule was set to take effect in September.
-
The company still has ambitions to sell the business.
